(Press-News.org) A new research study published in JMIR Diabetes evaluated the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutic program for the management of glycemic control and weight in people with type 2 diabetes mellitus. The study led by Shilpa Joshi, Arbinder Singal, and colleagues found significant improvements in both blood glucose levels and weight management in participants enrolled in the 90-day program.
The Fitterfly Diabetes CGM program, delivered through the Fitterfly mobile app coupled with continuous glucose monitoring (CGM) technology, provides users with tailored recommendations on nutrition based on personalized glycemic response data, exercise, and behavior modifications to help manage type 2 diabetes. The program is designed to provide individuals with the tools they need to manage their condition effectively and make long-term lifestyle changes that would support their overall health.
This study analyzed de-identified data of 109 participants with type 2 diabetes. The program was delivered in 3 phases. First, the participants’ CGM readings were observed for 1 week; next, they received diet- and exercise-based interventions via Fitterfly app and coaches (nutritionists, psychologists, and physiotherapists); and finally, the researchers tracked whether the participants were able to sustain these newly introduced lifestyle modifications over the next 3 months.
The researchers found that, at the end of the 90-day program, about 85% of all participants observed an average reduction of 1.2% in hemoglobin A1c (HbA1c) levels, an important indicator of glycemic control. The reduction was even higher, at about 2.6%, for those participants who started the program with an HbA1c level greater than 9%. The study participants also lost an average of 2.05 kg body weight, and their BMI reduced by 0.74 kg/m2.
Dr Arbinder Singal, CEO and cofounder of Fitterfly, said, “Type 2 diabetes is a huge health care concern in India. With the use of newer tools such as digital therapeutics now getting adopted by people and enterprise partners, and getting prescribed by physicians, we are bridging the gap for behavior change. The study affirms our belief that digital therapeutic programs can provide clinically validated outcomes and help the population at scale.”
The program's easy-to-use app interface and personalized approach make it a promising option for individuals looking to improve their health and manage diabetes effectively. Interestingly, the study also found that participants who engaged more with the app throughout the program’s duration had better clinical outcomes, especially with regard to weight reduction. Thus, Fitterfly’s CGM program could be a valuable tool for health care professionals in managing type 2 diabetes and supporting weight loss goals.
###
About Fitterfly
Fitterfly is a healthtech start-up working in the area of metabolic health offering outcome-focused digital therapeutic programs for conditions like diabetes, obesity, and heart disease. Founded in 2016 by Dr Arbinder Singal and Shailesh Gupta, Fitterfly has over 300 employees and has headquarters in Mumbai, India. The Fitterfly management team comprises senior doctors, nutritionists, fitness experts, psychologists, management experts, and technologists working together with the sole aim of preventing, reversing, and managing metabolic health conditions such as prediabetes, diabetes, obesity, hypertension, and heart disease, thereby increasing quality of life and health for people.
Fitterfly has presented and published more than 50+ abstracts and papers on outcomes and impact of technology in disease management. Apart from path-breaking research, Fitterfly has won several coveted awards in the start-up and health care arena, such as Economic Times Healthtech Start-up of the Year 2022, Zee News Healthtech Start-up of the Year 2022, Global Digital Health Award 2022, RSSDI Award for Innovation in Diabetes 2021, Medix Healthtech Challenge 2021, and Healthtech Start-up of the Year 2021 by Entrepreneur.
More information about Fitterfly is available at www.fitterfly.com or connect with us via Twitter, Linkedin, Youtube, Facebook, and Instagram.
About JMIR Publications
JMIR Publications is a leading, born-digital, open access publisher of 30+ academic journals and other innovative scientific communication products that focus on the intersection of health, and technology. Its flagship journal, the Journal of Medical Internet Research, is the leading digital health journal globally in content breadth and visibility, and is the largest journal in the medical informatics field.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media contact: communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
Please cite the original article as:
Joshi S, Verma R, Lathia T, Selvan C, Tanna S, Saraf A, Tiwaskar M, Modi A, Kalra S, K V, Chitale M, Malde F, Abdul Khader M, Singal AK
Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
JMIR Diabetes 2023;8:e43292
doi: 10.2196/43292
PMID: 3713392
END
Animal studies indicate that a new COVID-19 vaccine developed at Rutgers may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines.
“We need a better vaccine, one that provides years of robust protection with fewer booster shots against a variety of SARS-CoV-2 strains. Our data suggest this vaccine candidate might be able to do that,” said Stephen Anderson, associate professor of Molecular Biology and Biochemistry in SAS, resident member of the Rutgers Center for Advanced ...
For millions of people with seasonal allergies, springtime means runny noses, excessive sneezes and itchy eyes. And, as with many things, climate change appears to be making allergy season even worse. Researchers reporting in ACS Earth and Space Chemistry have shown that common allergen-producing plants ryegrass and ragweed emit more smaller, “subpollen particles” (SPPs) than once thought, yet climate would likely be most affected by their intact pollen grains, which can boost cloud formation.
In addition to annoying sinuses, pollen naturally functions as a ...
Discarded or drifting in the ocean, plastic debris can accumulate on the water’s surface, forming floating islands of garbage. Although it’s harder to spot, researchers suspect a significant amount also sinks. In a new study in ACS’ Environmental Science & Technology, one team used computer modeling to study how far bits of lightweight plastic travel when falling into the Mediterranean Sea. Their results suggest these particles can drift farther underwater than previously thought.
From ...
A team of Florida State University researchers has further developed a new generation of organic-inorganic hybrid materials that can improve image quality in X-ray machines, CT scans and other radiation detection and imaging technologies.
Professor Biwu Ma from the Department of Chemistry and Biochemistry and his colleagues have developed a new class of materials that can act as highly efficient scintillators, which emit light after being exposed to other forms of high energy radiations, such as X-rays.
The team’s most recent study, published in Advanced Materials, is an improvement upon their previous research to develop better scintillators. The new design concept produces ...
Astronomers used NASA’s James Webb Space Telescope to image the warm dust around a nearby young star, Fomalhaut, in order to study the first asteroid belt ever seen outside of our solar system in infrared light. But to their surprise, the dusty structures are much more complex than the asteroid and Kuiper dust belts of our solar system. Overall, there are three nested belts extending out to 14 billion miles (23 billion kilometers) from the star; that’s 150 times the distance of Earth from the Sun. The scale of the outermost belt is roughly twice the scale of our ...
Irvine, CA – May xx, 2023 – In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).
The study, titled, “Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition,” was published in the Proceedings of the National Academy of Sciences.
“In this study, we introduce a new class of therapeutics called ‘Stress ...
ST. LOUIS, MO - May 8, 2023 – Graduate student Amie Fornah Sankoh recently stood in front of 150 colleagues family and friends at the Donald Danforth Plant Science Center to defend her thesis, Investigating the Effects of Salicylic acid on Intercellular Trafficking via Plasmodesmata in Nicotiana benthamiana. Upon her successful defense, Dr. Amie Sankoh became the first Deaf, Black woman to receive a PhD in any STEM discipline.
Completing a PhD is a challenging undertaking for anyone; to do so without easy access to the kinds of verbal communication that hearing people ...
CHICAGO, May 8, 2023 – Macrophages, a type of white blood cell, defend the body by engulfing and digesting foreign particles, such as bacteria, viruses, and dead cells. The immune cells also tend to accumulate in solid tumors, so tracking them could enable new ways to detect cancer and the earliest stages of metastasis.
As part of the 184th Meeting of the Acoustical Society of America, Ashley Alva of the Georgia Institute of Technology will describe how attaching microbubbles to macrophages can create high-resolution and sensitive tracking images useful for disease diagnosis. Her presentation, “Tracking macrophages ...
CHICAGO, May 8, 2023 – Imagine a cocktail party full of 3D-printed, humanoid robots listening and talking to each other. That seemingly sci-fi scene is the goal of the Augmented Listening Laboratory at the University of Illinois Urbana-Champaign. Realistic talking (and listening) heads are crucial for investigating how humans receive sound and developing audio technology.
The team will describe the talking human head simulators in their presentation, “3D-printed acoustic head simulators that talk and move,” on Monday, May 8, at 12:15 p.m. Eastern U.S. in the Northwestern/Ohio State room of the Chicago Marriott Downtown Magnificent Mile Hotel. The talk comes as part of ...
The World Mitochondria Society is organizing its 14th world conference, Targeting Mitochondria 2023, on October 11-13 at the Steigenberger Hotel Am Kanzleramt, Berlin. Targeting Mitochondria 2023 will address the latest advances and perspectives in mitochondrial research and provide an outlook on future mitochondrial therapies.
Volkmar Weissig, president of the World Mitochondria Society, and Marvin Edeas, president of the scientific committee, said, "This year we will have specific sessions on innovations such as mitochondria in space, exosome-based mitochondrial ...
